Key facts
- Mendaera’s last known valuation is $180.0M.
- It has raised $99.0M; the latest was Early Stage VC ($74.5M) in Sep 2024.
- Notable investors include Gaingels, Founders Fund, Lux Capital, Operator Partners, Signal Rank — 14 tracked in total.
- Status: Privately Held (backing).
Leadership
- Alexander HassanVice President
- Eric DavidsonExecutive Officer
- Jason WilsonChief Technology Officer & Founder
- Joshua DeFonzoChief Executive Officer & Founder
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Mendaera
- ·The full record, as it builds
Funding rounds
No funding rounds for Mendaera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mendaera
Developer of medical robotics and advanced technology designed to perform precise and consistent interventions. The company's platform integrates handheld robotics, ultrasound imaging, artificial intelligence, and connectivity, enabling users to digitize clinical judgment and accelerate technical expertise to improve patient care and its delivery.
- Sector
- Healthcare
- HQ
- San Mateo, CA, United States
- Founded
- 2020
- Employees
- 65
- Website
- mendaera.com/
- Ownership
- Privately Held (backing)
Mendaera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mendaera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mendaera in its N-PORT filings yet. We sweep new filings monthly.